OOIR: Observatory of International Research

Papers

(The H4-Index of Medicinal Research Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
	229
	211
Key characters of glycodrugs	195
The role and prospect of lysine‐specific demethylases in cancer chemoresistance	171
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders	147
Galectin‐8 inhibition and functions in immune response and tumor biology	145
In Memoriam: Professor Minyong Li (1976–2025)	116
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy	115
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns	110
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment	95
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers	91
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery	87
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions	84
New drug approvals for 2022: Synthesis and clinical applications	83
Front Cover Image, Volume 45, Issue 1	82
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses	81
Issue Information	80
	80
Current and emerging approaches to noncompetitive AR inhibition	77
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel	74
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer	65
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders	63
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents	63
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases	47
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review	46

Targeting lysosomal quality control as a therapeutic strategy against aging and diseases	43
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing	42
Mitochondrial quality control proteases and their modulation for cancer therapy	42
Smart Integration of Structural Biology and Medicinal Chemistry to Unlock Target‐Driven Drug Discovery	41
Current nanocomposite advances for biomedical and environmental application diversity	39
Enhancing healthy aging with small molecules: A mitochondrial perspective	39
Emerging roles of nerve‐bone axis in modulating skeletal system	39
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators	39
Issue Information	37
α‐Synuclein in Parkinson's Disease: From Bench to Bedside	37
Human Cyclophilins—An Emerging Class of Drug Targets	36
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis	36
Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy	36